Regulations.gov document
Guidance for Industry: Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components…
Notice · FDA-2001-D-0254 · posted Sep 25, 2012
Key facts
| Document ID | FDA-2001-D-0254-0039 |
|---|---|
| Title | Guidance for Industry: Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2001-D-0254 |
| Posted | Sep 25, 2012 |
| Federal Register citation | 77 FR 59000 |
| FR document number | 2012-23542 |
| Comment period opens | Sep 25, 2012 |
| Effective date | Sep 25, 2012 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: